RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 70 filers reported holding RUBIUS THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $527,000 | -38.8% | 95,600 | +7.5% | 0.00% | -100.0% |
| Q4 2021 | $861,000 | -45.8% | 88,900 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $1,590,000 | -19.1% | 88,900 | +10.4% | 0.00% | 0.0% |
| Q2 2021 | $1,965,000 | -10.6% | 80,500 | -2.9% | 0.00% | 0.0% |
| Q1 2021 | $2,197,000 | +297.3% | 82,900 | +13.7% | 0.00% | – |
| Q4 2020 | $553,000 | +51.5% | 72,900 | 0.0% | 0.00% | – |
| Q3 2020 | $365,000 | -16.3% | 72,900 | 0.0% | 0.00% | – |
| Q2 2020 | $436,000 | +60.9% | 72,900 | +19.7% | 0.00% | – |
| Q1 2020 | $271,000 | -53.2% | 60,900 | 0.0% | 0.00% | -100.0% |
| Q4 2019 | $579,000 | +24.2% | 60,900 | +2.5% | 0.00% | – |
| Q3 2019 | $466,000 | -50.1% | 59,400 | 0.0% | 0.00% | -100.0% |
| Q2 2019 | $934,000 | – | 59,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 38,296,526 | $290,671,000 | 5.29% |
| HARBOURVEST PARTNERS LLC | 986,878 | $7,490,000 | 2.93% |
| Abbot Financial Management, Inc. | 537,000 | $4,076,000 | 2.35% |
| Artal Group S.A. | 3,778,913 | $28,682,000 | 0.62% |
| HITE Hedge Asset Management LLC | 88,740 | $674,000 | 0.16% |
| Virtus ETF Advisers LLC | 33,793 | $256,000 | 0.11% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 394,909 | $2,997,000 | 0.03% |
| Baillie Gifford | 4,710,061 | $35,749,000 | 0.02% |
| Caption Management, LLC | 86,000 | $652,000 | 0.02% |
| Blueshift Asset Management, LLC | 14,626 | $111,000 | 0.01% |